Innovative therapies demand extraordinary means. With an international team of renowned scientists, proven competence in clinical development, and a global network of experts and reliable partners, we differentiate our pipeline by using an indication-driven, technology-agnostic approach. As innovator for antiviral and antibacterial therapies, we target indications with high medical need today and prepare for future threats.
Our main pipeline focus is on indications with a particularly high, current medical need, for which no efficient solutions are available. Finding these solutions is one of AiCuris’ two priorities, and we highly invest into the appropriate selection of indication and approach. Our diverse program targets both viral and bacterial areas of unmet medical need, addressing niche markets as well as big indications.
If you or your company are interested in partnering with AiCuris, please contact us.